Excuse me while I go ugly-cry: “Gilead’s experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.”
https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html
Gabe Ortíz /
npub1f4…jsyc8
2024-06-21 04:38:02
Author Public Key
npub1f4tnnfy0utykm8ajvjnwkl4d0d3jhwcnq94el0jsuze70mnms2lqcjsyc8Published at
2024-06-21 04:38:02Event JSON
{
"id": "8b0246a106b5d2758f51af86bde1cf8286fd2846d9a904f580e90abfe44bafad",
"pubkey": "4d5739a48fe2c96d9fb264a6eb7ead7b632bbb13016b9fbe50e0b3e7ee7b82be",
"created_at": 1718937482,
"kind": 1,
"tags": [
[
"proxy",
"https://mastodon.social/@tusk81/112652286833957533",
"web"
],
[
"proxy",
"https://mastodon.social/users/tusk81/statuses/112652286833957533",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://mastodon.social/users/tusk81/statuses/112652286833957533",
"pink.momostr"
]
],
"content": "Excuse me while I go ugly-cry: “Gilead’s experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.”\n\nhttps://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html",
"sig": "7c6542fd8d0610a5221e9974a3008310d5cfc83b06024dedc2172c238f65d2bff6e94f2efa9a3a6ddbeda33780ba0a38bdf54f2682c74a83ee730e669dd353a4"
}